What does CUSIP 74587V107 represent in this 13F holders report?

CUSIP 74587V107 is the security identifier for PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in Q3 2016?

145 institutional investors reported PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock for Q3 2016. Use the holders table for investor-level position and value details.

PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class: Equity / Common Stock
Shares outstanding: 49,633,071
Total 13F shares: 29,992,904
Share change: -1,821,240
Total reported value: $2,010,275,475
Put/Call ratio: 81%
Price per share: $67.05
Number of holders: 145
Value change: +$5,538,941
Number of buys: 89
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q4 2016
Previous quarter: Q2 2016

Recent filing periods for CUSIP 74587V107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	11%	5,686,668	$169,406,000	—	30 Jun 2016	13F
FMR LLC	13F	Company	9.8%	4,873,963	$145,195,000	—	30 Jun 2016	13F
ORBIMED ADVISORS LLC	13F	Company	6%	2,964,025	$88,298,000	—	30 Jun 2016	13F
JANUS HENDERSON INVESTORS US LLC	13F	Company	5.1%	2,540,331	$75,675,000	—	30 Jun 2016	13F
VANGUARD GROUP INC	13F	Company	3.9%	1,929,407	$57,477,000	—	30 Jun 2016	13F
PFM Health Sciences, LP	13F	Company	3%	1,471,879	$43,847,000	—	30 Jun 2016	13F
Point72 Asset Management, L.P.	13F	Company	2.9%	1,415,800	$42,177,000	—	30 Jun 2016	13F
STATE STREET CORP	13F	Company	2.1%	1,055,380	$31,441,000	—	30 Jun 2016	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	2%	1,016,874	$30,293,000	—	30 Jun 2016	13F
Capital Research Global Investors	13F	Company	1.4%	676,600	$20,156,000	—	30 Jun 2016	13F
BlackRock Fund Advisors	13F	Company	1.2%	602,071	$17,936,000	—	30 Jun 2016	13F
Tourbillon Capital Partners, L.P.	13F	Company	1.2%	587,126	$17,490,000	—	30 Jun 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.2%	582,564	$17,355,000	—	30 Jun 2016	13F
CORNERSTONE CAPITAL MANAGEMENT LLC	13F	Company	0.97%	482,707	$14,380,000	—	30 Jun 2016	13F
EverPoint Asset Management, LLC	13F	Company	0.91%	450,000	$13,406,000	—	30 Jun 2016	13F
BB BIOTECH AG	13F	Company	0.87%	431,991	$12,869,000	—	30 Jun 2016	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.8%	395,750	$11,789,000	—	30 Jun 2016	13F
WEATHERBIE CAPITAL, LLC	13F	Company	0.57%	280,985	$8,371,000	—	30 Jun 2016	13F
NORTHERN TRUST CORP	13F	Company	0.55%	272,695	$8,124,000	—	30 Jun 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.54%	266,479	$7,938,000	—	30 Jun 2016	13F
Tekla Capital Management LLC	13F	Company	0.52%	260,200	$7,751,000	—	30 Jun 2016	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.5%	246,600	$7,346,000	—	30 Jun 2016	13F
JPMORGAN CHASE & CO	13F	Company	0.47%	231,875	$6,907,000	—	30 Jun 2016	13F
Asset Management One Co., Ltd.	13F	Company	0.35%	172,207	$5,218,000	—	30 Jun 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.3%	146,950	$4,377,000	—	30 Jun 2016	13F
PAULSON & CO. INC.	13F	Company	0.29%	145,800	$4,343,000	—	30 Jun 2016	13F
EATON VANCE MANAGEMENT	13F	Company	0.29%	142,000	$4,230,000	—	30 Jun 2016	13F
UBS Group AG	13F	Company	0.29%	141,970	$4,229,000	—	30 Jun 2016	13F
D. E. Shaw & Co., Inc.	13F	Company	0.27%	135,727	$4,043,000	—	30 Jun 2016	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.27%	133,722	$3,984,000	—	30 Jun 2016	13F
NORGES BANK	13F	Company	0.25%	124,247	$3,701,000	—	30 Jun 2016	13F
TEACHERS ADVISORS, LLC	13F	Company	0.24%	121,192	$3,610,000	—	30 Jun 2016	13F
Bank of New York Mellon Corp	13F	Company	0.23%	111,917	$3,333,000	—	30 Jun 2016	13F
Emerald Acquisition Ltd.	13F	Company	0.22%	110,788	$3,301,000	—	30 Jun 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.21%	105,022	$3,129,000	—	30 Jun 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.2%	97,416	$2,900,000	—	30 Jun 2016	13F
S.c.a. Candriam	13F	Individual	0.19%	92,000	$2,741,000	—	30 Jun 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.18%	91,504	$2,726,000	—	30 Jun 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.16%	79,231	$2,360,000	—	30 Jun 2016	13F
CREDIT SUISSE AG/	13F	Company	0.12%	60,589	$1,805,000	—	30 Jun 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.12%	57,300	$1,707,000	—	30 Jun 2016	13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	13F	Company	0.1%	51,775	$1,542,000	—	30 Jun 2016	13F
FEDERATED HERMES, INC.	13F	Company	0.1%	50,139	$1,494,000	—	30 Jun 2016	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.1%	50,000	$1,490,000	—	30 Jun 2016	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.09%	46,840	$1,395,000	—	30 Jun 2016	13F
Swiss National Bank	13F	Company	0.09%	45,130	$1,344,000	—	30 Jun 2016	13F
Orbis Allan Gray Ltd	13F	Company	0.09%	43,854	$1,306,000	—	30 Jun 2016	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.09%	42,400	$1,263,000	—	30 Jun 2016	13F
ABERDEEN ASSET MANAGEMENT PLC/UK	13F	Company	0.07%	36,220	$1,079,000	—	30 Jun 2016	13F
FRANKLIN STREET ADVISORS INC /NC	13F	Company	0.07%	34,025	$1,014,000	—	30 Jun 2016	13F

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q3 2016

As of 30 Sep 2016, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,992,904 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP, L.L.C., FMR LLC, ORBIMED ADVISORS LLC, JANUS CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Point72 Asset Management, L.P., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, and Redmile Group, LLC. This page lists 145 institutional shareholders reporting positions in this security for the Q3 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders

107

Q3 2016 holders

145

Holder diff

Investor	Q2 2016 Shares	Q3 2016 Shares	Share Diff	Share Chg %	Q2 2016 Value $	Q3 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.